Chávez-Mondragón, E., Palacio, C., Soto-Gómez, A., Villanueva-Nájera, M., De Wit-Carter, G., Suárez-Velasco, R., . . . Muñoz-Villegas, P. (2019). Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation. Clin Ophthalmol.
Citação norma ChicagoChávez-Mondragón, Eduardo, Claudia Palacio, Abraham Soto-Gómez, Miguel Villanueva-Nájera, Guillermo De Wit-Carter, Ruben Suárez-Velasco, Leopoldo Baiza-Duran, Oscar Olvera-Montaño, and Patricia Muñoz-Villegas. "Efficacy and Safety of Bromfenac 0.09% and Sodium Hyaluronate 0.4% Combination Therapy, Versus Placebo in Patients With Pterygium I–III for Clinical Signs On Ocular Inflammation." Clin Ophthalmol 2019.
Citação norma MLAChávez-Mondragón, Eduardo, et al. "Efficacy and Safety of Bromfenac 0.09% and Sodium Hyaluronate 0.4% Combination Therapy, Versus Placebo in Patients With Pterygium I–III for Clinical Signs On Ocular Inflammation." Clin Ophthalmol 2019.